Abstract View: 1633
PDF Download: 828
Epidemiology and Prevention
Sodium-glucose co-transporter-2 inhibitors in renal failure patients; expanding indications and prospective trends
Hamid Nasri
1 
, Sepideh Ghanbari-nejad
1 , Mina Dehghani
1 , Anastasia Dieti
2* 1 Nickan Research Institute, Isfahan, Iran.
2 Department of Life Sciences, School of Sciences, European University Cyprus, Nicosia 2404, Cyprus.
*Corresponding Author: Corresponding Author: Anastasia Dieti, Email: a.dieti@external.euc.ac.cy, , Email:
anastasiadieti@yahoo.co.uk
Citation: Nasri H, Ghanbari-nejad S, Dehghani M, Dieti A. Sodium-glucose co-transporter-2 inhibitors in renal failure patients; expanding indications and prospective trends. J Ren Endocrinol. 2023;9:e25084. doi: 10.34172/jre.2023.25084.